Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis

Leandri, Massimo; Lundardi, G; Inglese, Matilde; Messmer-Uccelli, M; Mancardi, Gianluigi; Gottlieb, A.; Solaro, Claudio

doi:10.1007/s004150070157

Cited by 74 publications

(31 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…132 In the second, pain relief was achieved in 16 out of 18 patients. 133 Typically, doses used were up to 400 mg daily. (These two reports are from the same authors, so there may be overlap in the patients included.…”

Section: Lamotriginementioning

confidence: 99%

Treatments for spasticity and pain in multiple sclerosis: a systematic review

Beard

Hunn²,

Wight³

2003

Health Technol Assess

237

131

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents, York Publishing Services by:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS and public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please contact York Publishing Services at the address above. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to York Publishing Distribution and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.ncchta.org/htacd.htm). Or contact York Publishing Services (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTATreatments for spasticity and pain in multiple sclerosis: a systematic review NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.The research reported in this monograph was commissioned by the HTA Programme and funded as project number 99/05/03. Technology assessment reports are completed in a limited time to inform decisions in key areas by bringing together evidence on the use of the technology concerned.The views expressed in this publication are those of the authors and not necessarily those of the HTA Programme or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for any recommendations made by the authors. HTA Programme Director:Professor Kent Woods Series Editors:Professor Andrew Stevens, Dr Ken Stein, Professor John Gabbay, Dr Ruairidh Milne, Dr Chris Hyde and Dr Rob Riemsma Managing Editors:Sally Bailey and ...

show abstract

Section: Lamotriginementioning

confidence: 99%

Treatments for spasticity and pain in multiple sclerosis: a systematic review

Beard

Hunn²,

Wight³

2003

Health Technol Assess

237

131

View full text Add to dashboard Cite

show abstract

“…It is unknown whether differences in disease mechanism causing nerve pain alter the responsiveness to analgesia. 10 There have been few randomized controlled trials (RCTs) of pharmacotherapeutics for MS pain, and most of those studies have focused on treating trigeminal neuralgia in MS. [11][12][13][14][15] Three RCTs examined the use of cannabinoid derivatives (oral or oropharyngeal spray preparations) for MSrelated pain including dysesthetic limb pain and painful spasms. The studies found some evidence of effectiveness in pain relief, but the utility of these medications is limited by safety concerns, adverse effects, and their status with the Drug Enforcement Agency.…”

Section: Discussionmentioning

confidence: 99%

A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis

Brown¹,

Slee²

2015

International Journal of MS Care

View full text Add to dashboard Cite

show abstract

“…54 Lamotrigine was recently validated for use in refractory trigeminal neuralgia, especially due to multiple sclerosis. 51,52,55 Gabapentin in the Treatment of Periodic Limb Movement Disorder of Sleep Periodic limb movements of sleep occur as an asleep phenomenon and are characterized by periodic episodes of repetitive and highly stereotyped limb movements. These patients typically have complaints of insomnia or excessive sleepiness with no other disorder to explain the symptoms.…”

Section: Gabapentin In the Treatment Of Trigeminal Neuralgiamentioning

confidence: 99%

“…52 Referral to an asthma specialist (usually an allergist or pulmonologist)-particularly for patients with severe asthma-may help improve medical adherence to asthma management guidelines and patient QOL. [53][54][55] Westley et al 56 reviewed the charts of 70 moderate-to-severe asthma patients enrolled in a large staff model HMO before and after referral to an asthma specialist (either allergist or pulmonologist). Following consultation with the specialist, there was a 45% decrease in the number of office visits for asthma, a 55% decrease in acute care visits, a 67% decrease in hospitalizations, and a cost savings of $2,100 per patient.…”

Section: Impact Of Managed Care Interventionmentioning

confidence: 99%

Unmet Needs in the Treatment of Allergic Asthma: Potential Role of Novel Biologic Therapies

Storms

2003

JMCP

View full text Add to dashboard Cite

Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis

Cited by 74 publications

References 9 publications

Treatments for spasticity and pain in multiple sclerosis: a systematic review

Treatments for spasticity and pain in multiple sclerosis: a systematic review

A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis

Unmet Needs in the Treatment of Allergic Asthma: Potential Role of Novel Biologic Therapies

Contact Info

Product

Resources

About